SOURCE: SuperSonic Imagine

SuperSonic Imagine

November 10, 2016 12:15 ET

SuperSonic Imagine to Feature its Non-Invasive, 60-Second Liver Exam at The Liver Meeting 2016

Attendees in Boston will see demonstrations of Aixplorer with real-time ShearWave Elastography™ and several clinical research abstracts on its use for liver stiffness measurement

AIX-EN-PROVENCE, FRANCE--(Marketwired - Nov 10, 2016) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will feature Aixplorer with real-time ShearWave Elastography (SWE™) at The Liver Meeting 2016 November 11 - 15 in Boston. The Company will be exhibiting in conjunction with Sandhill Scientific, Inc., their exclusive distributor in the United States for providing the Aixplorer® ultrasound system to Gastroenterologists and Hepatologists. Attendees of this meeting, held by the American Association for the Study of Liver Diseases (AASLD), will have the opportunity to learn more about SWE's value to patients with chronic liver disease.

Real-time ShearWave Elastography (SWE), available only on the Aixplorer ultrasound system, is a 60-second non-invasive exam that can be used for imaging patients with chronic liver disease. SWE offers the advantage of a real-time image of liver anatomy, while also providing a color coded map and quantitative measurement of liver stiffness, making it an important parameter to enhance liver diagnostics. About 100 international publications have demonstrated the reliability and effectiveness of SuperSonic Imagine's SWE in this area. In addition, eight abstracts accepted by AASLD reporting results from clinical research studies using SuperSonic's imagine's technology will be presented as posters during the meeting:

Friday, November 11

Diagnostic accuracy of Shear Wave Elastography for the assessment of liver stiffness in pediatric patients with fatty liver disease (Abstract #546)
Matteo Garcovich et al.

#654 Role of shear wave elastography in patients on high dose methotrexate: A prospective study (Abstract 654)
Robert S. Rahimi et al.

Saturday, November 12

Regression of Liver Fibrosis assessed by non-invasive methods in Patients with Chronic Hepatitis C who Achieved Sustained Virologic Response after DAAs Treatment (Abstract 824)
Yana Davidov et al.

Prospective Comparison between Transient Elastography, Supersonic Shear Imaging, and ARFI Imaging for Predicting Fibrosis in Subjects with NAFLD (Abstract 1058)
Won Kim et al.

Improvement in Non-Invasive Hepatic Parameters of Nonalcoholic Fatty Liver Disease in Obese Uncontrolled Type 2 Diabetes Mellitus Patients who underwent Endoscopic Duodenal-Jejunal Bypass Liner (Endobarrier) Implantation (Abstract 1105)
Oranit Cohen-Ezra et al.

Probiotics do not improve hepatic outcomes after Laparoscopic Sleeve Gastrectomy surgery: a randomized clinical trial (Abstract 1123)
Shiri Sherf Dagan et al.

Sunday, November 13

2-dimensional shear wave elastography rather than HVPG significantly improves MELD-Na to predict survival in decompensated cirrhosis patients (Abstract 1406)
Maja Thiele et al.

"SuperSonic Imagine's dedication to advancing the evaluation of chronic liver disease has enabled us to develop innovative solutions such as image-guided ShearWave Elastography, an accurate, easy-to-use and pain-free liver exam," explained SuperSonic Imagine Founder and Chief Innovation Officer Jacques Souquet. "We are excited to share this technology's capabilities at The Liver Meeting, where we know hepatologists from around the world will share our enthusiasm for the non-invasive quantification of liver stiffness."

SSI will be exhibiting at booth #313 throughout The Liver Meeting.

The Liver Meeting® is a registered trademark of the American Association for the Study of Liver Diseases.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™ Elastography (SWE™), UltraFast™ Doppler and more recently Angio PL.U.S* - Planewave UltraSensitive™ Imaging.

ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI. For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

*Pending FDA 510(k) clearance

Contact Information

  • Contact information:

    SuperSonic Imagine
    Bernard Doorenbos
    CEO
    Email Contact
    +33 6 15 66 64 68

    SuperSonic Imagine
    Marketing & Communication
    Emmanuelle Vella
    Email Contact
    +33 4 86 79 03 27

    NewCap
    Investor Relations - EU
    Pierre Laurent / Florent Alba
    Email Contact
    +33144719855

    Pascale Communication
    Media Relations - US
    Amy Phillips
    Email Contact
    +1 412 327 9499